Severe Acute Respiratory Syndrome
"Severe Acute Respiratory Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.
| Descriptor ID |
D045169
|
| MeSH Number(s) |
C02.782.600.550.200.750 C08.730.730
|
| Concept/Terms |
Severe Acute Respiratory Syndrome- Severe Acute Respiratory Syndrome
- Respiratory Syndrome, Severe Acute
- SARS (Severe Acute Respiratory Syndrome)
- Respiratory Syndrome, Acute, Severe
|
Below are MeSH descriptors whose meaning is more general than "Severe Acute Respiratory Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Severe Acute Respiratory Syndrome".
This graph shows the total number of publications written about "Severe Acute Respiratory Syndrome" by people in this website by year, and whether "Severe Acute Respiratory Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 1 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 2 | 0 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2020 | 5 | 6 | 11 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Severe Acute Respiratory Syndrome" by people in Profiles.
-
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement. Vaccine. 2020 11 03; 38(47):7533-7541.
-
Reentry Reflections: Views on COVID-19 From a Global Health Trainee. Pediatrics. 2020 09; 146(3).
-
Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate. J Pharm Sci. 2017 08; 106(8):1961-1970.
-
Noninvasive mechanical ventilation in high-risk pulmonary infections: a clinical review. Eur Respir Rev. 2014 Dec; 23(134):427-38.
-
Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library. J Comb Chem. 2005 Sep-Oct; 7(5):648-56.
-
An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J Pathol. 2005 Jul; 206(3):251-9.
-
Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. Eur J Clin Microbiol Infect Dis. 2005 Mar; 24(3):165-71.
-
Health risks to air travelers. Infect Dis Clin North Am. 2005 Mar; 19(1):67-84.
-
Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome. Clin Exp Immunol. 2005 Jan; 139(1):112-9.
-
Genetic variation of SARS coronavirus in Beijing Hospital. Emerg Infect Dis. 2004 May; 10(5):789-94.